6Inoue T, Hayashi M, Takayanagi K, et al. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypervholesterolemic patients. Atherosclerosis 2002; 160(2):369. 被引量：1
7Takahashi M, Ogata Y, Okazaki H, et al. Fluvastatin enhances apoptosis in cytokine-stimulated vascular smooth muscle cells. J Cardiovasc Pharmacol 2002;39(2):310. 被引量：1
8Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhihitors. Clin Pharmarcokinet 2002; 41(5):343. 被引量：1
9Crouch MA. Effective use of statins to prevent coronary heart disease. Am Fam Physician 2001;63(2):309. 被引量：1
5[1]Ginsberg HN. Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens[J]. Clin Cardiol, 1995,18(6):307-312. 被引量：1
6[2]Corsini A. Direct effects of statins on the vascular wall[J]. J Cardiovasc Pharmacol, 1998,31(5):773-778. 被引量：1
7[3]Chamley-campbell J, Campbell GR, Ross R. The smooth muscle in culture[J]. Physiol Rev, 1979,59(1):1-61. 被引量：1
8[4]Miquel K, Pradines A, Favre G, et al. Farnesol and geranylgeraniol induce actin cytoskelotin disorganization and apoptosis in A549 lung adenocarcinoma cell[J]Biochem Biophys Res Commu, 1996, 225(3): 869-876. 被引量：1
9[5]Singh SV, Mohas RR, Agrral R, et al. Novel anticarcinogenic activity of an organosulfide from Garlic: inhibition of H-ras oncogene transformed tummer growth in vivo by dissulfide is associated with inhibition of p21ras processing[J]. Biochem Biophys Res Commu, 1996, 225(2):660-665. 被引量：1
10[6]Marrero MB, Schieffer B, Bernstein KE, et al. Angiotensin Ⅱ-induced tyrosine phosphorylation in mesangial and vascular smooth muscle cells[J]. Clin Exp Pharmacol Physiol, 1996,23(1):83-88. 被引量：1
